Evidence Explorer · MS-N268 · Massage and aromatherapy · anxiety and depression · Appraised November 7, 2026

A large pragmatic trial found no significant improvement in clinical anxiety or depression at the 10-week primary follow-up, although short-term and self-reported anxiety signals favored aromatherapy massage.

Evidence at a glance

• Benefit signal: Possible brief relief after the treatment course, without a durable primary-outcome benefit.
• Certainty: Moderate confidence that this program did not produce a large sustained effect; lower confidence about short-term benefit and the added value of essential oil versus massage and attention.
• Risk context: Massage may cause soreness or be unsafe over fragile tissue, clots or bone disease. Essential oils can irritate skin, trigger allergy or headache and should never be swallowed as a cancer treatment.
• Cancer-control relevance: This is supportive-care evidence. It does not test tumor response, recurrence or survival.

What was studied

A pragmatic multicenter trial at four U.K. cancer centers and a hospice randomized 288 people referred with clinical anxiety and/or depression to a course of aromatherapy massage plus usual supportive care or usual supportive care alone. The accessible abstract did not verify the essential-oil formulation, massage dose, analyzed denominator or masking procedures.

What the study found

At 10 weeks, the primary clinical anxiety/depression outcome did not significantly favor aromatherapy massage (OR 1.3, 95% CI 0.9–1.7; p=.1). A benefit was reported at six weeks (OR 1.4, 95% CI 1.1–1.9; p=.01), and self-reported anxiety favored massage at six and ten weeks. A later Cochrane review judged the wider massage/aromatherapy evidence very low quality and inconsistent.

What this does not establish

This trial does not prove that essential oils add benefit beyond massage, supportive attention or expectation. A short-lived anxiety change is not a substitute for assessment and treatment of depression, panic, delirium or suicidal thinking, and it says nothing about cancer control.

Safety and practical context

Use diluted, clearly identified products and patch-test when appropriate. Avoid broken or irradiated skin and stop for rash, wheeze, headache or nausea. People with severe depression, panic or safety concerns need prompt mental-health and oncology support.

Questions for the care team

• Is anxiety or depression severe enough to need counseling, medication or urgent mental-health assessment?
• Which essential oil and dilution would be used, and are there allergy or skin concerns?
• Would plain massage or another relaxation approach offer similar comfort without fragrance exposure?

Sources and identifiers

• Multicenter randomized controlled trial — PMID 17290062
• Cochrane review of massage with or without aromatherapy

Funding and conflicts: The PubMed record identifies non-U.S. research support. Complete funding and conflict details were not verified beyond the abstract record.

Source access and dates: PubMed abstract and Cochrane evidence summary were appraised. Sources checked November 7, 2026. Last literature search November 7, 2026.

Educational evidence summary, not individualized medical advice. These approaches should complement—not replace—oncology, rehabilitation, palliative or symptom-directed care.